EMD-27754
CryoEM structure of Gq-coupled MRGPRX1 with ligand Compound-16
EMD-27754
Single-particle3.25 Å

Map released: 02/11/2022
Last modified: 30/10/2024
Sample Organism:
Homo sapiens
Sample: MRGPRX1-Gq BAM8-22
Fitted models: 8dwh (Avg. Q-score: 0.51)
Raw data: EMPIAR-11191, EMPIAR-11188
Deposition Authors: Liu Y
,
Cao C
,
Fay JF
,
Roth BL
Sample: MRGPRX1-Gq BAM8-22
Fitted models: 8dwh (Avg. Q-score: 0.51)
Raw data: EMPIAR-11191, EMPIAR-11188
Deposition Authors: Liu Y




Ligand recognition and allosteric modulation of the human MRGPRX1 receptor.
Liu Y
,
Cao C
,
Huang XP,
Gumpper RH,
Rachman MM
,
Shih SL
,
Krumm BE
,
Zhang S
,
Shoichet BK
,
Fay JF
,
Roth BL
(2023) Nat Chem Biol , 19 , 416 - 422









(2023) Nat Chem Biol , 19 , 416 - 422
Abstract:
The human MAS-related G protein-coupled receptor X1 (MRGPRX1) is preferentially expressed in the small-diameter primary sensory neurons and involved in the mediation of nociception and pruritus. Central activation of MRGPRX1 by the endogenous opioid peptide fragment BAM8-22 and its positive allosteric modulator ML382 has been shown to effectively inhibit persistent pain, making MRGPRX1 a promising target for non-opioid pain treatment. However, the activation mechanism of MRGPRX1 is still largely unknown. Here we report three high-resolution cryogenic electron microscopy structures of MRGPRX1-Gαq in complex with BAM8-22 alone, with BAM8-22 and ML382 simultaneously as well as with a synthetic agonist compound-16. These structures reveal the agonist binding mode for MRGPRX1 and illuminate the structural requirements for positive allosteric modulation. Collectively, our findings provide a molecular understanding of the activation and allosteric modulation of the MRGPRX1 receptor, which could facilitate the structure-based design of non-opioid pain-relieving drugs.
The human MAS-related G protein-coupled receptor X1 (MRGPRX1) is preferentially expressed in the small-diameter primary sensory neurons and involved in the mediation of nociception and pruritus. Central activation of MRGPRX1 by the endogenous opioid peptide fragment BAM8-22 and its positive allosteric modulator ML382 has been shown to effectively inhibit persistent pain, making MRGPRX1 a promising target for non-opioid pain treatment. However, the activation mechanism of MRGPRX1 is still largely unknown. Here we report three high-resolution cryogenic electron microscopy structures of MRGPRX1-Gαq in complex with BAM8-22 alone, with BAM8-22 and ML382 simultaneously as well as with a synthetic agonist compound-16. These structures reveal the agonist binding mode for MRGPRX1 and illuminate the structural requirements for positive allosteric modulation. Collectively, our findings provide a molecular understanding of the activation and allosteric modulation of the MRGPRX1 receptor, which could facilitate the structure-based design of non-opioid pain-relieving drugs.